Literature DB >> 22805170

Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia.

Samuel M Brown1, Jason P Jones, Dominik Aronsky, Barbara E Jones, Michael J Lanspa, Nathan C Dean.   

Abstract

BACKGROUND AND
OBJECTIVE: Appropriate triage of patients with community-acquired pneumonia (CAP) may improve morbidity, mortality and use of hospital resources. Worse outcomes from delayed intensive care unit (ICU) admission have long been suspected but have not been verified.
METHODS: In a retrospective study of consecutive patients with CAP admitted from 1996-2006 to the ICUs of a tertiary care hospital, we measured serial severity scores, intensive therapies received, ICU-free days, and 30-day mortality. Primary outcome was mortality. We developed a regression model of mortality with ward triage (and subsequent ICU transfer within 72 h) as the predictor, controlled by propensity for ward triage and radiographic progression.
RESULTS: Of 1059 hospital-admitted patients, 269 (25%) were admitted to the ICU during hospitalization. Of those, 167 were directly admitted to the ICU without current requirement for life support, while 61 (23%) were initially admitted to the hospital ward, 50 of those undergoing ICU transfer within 72 h. Ward triage was associated with increased mortality (OR 2.6, P = 0.056) after propensity adjustment. The effect was less (OR 2.2, P = 0.12) after controlling for radiographic progression. The effect probably increased (OR 4.1, P = 0.07) among patients with ≥ 3 severity predictors at admission.
CONCLUSIONS: Initial ward triage among patients transferred to the ICU is associated with twofold higher 30-day mortality. This effect is most apparent among patients with ≥ 3 severity predictors at admission and is attenuated by controlling for radiographic progression. Intensive monitoring of ward-admitted patients with CAP seems warranted. Further research is needed to optimize triage in CAP.
© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Year:  2012        PMID: 22805170      PMCID: PMC3544548          DOI: 10.1111/j.1440-1843.2012.02225.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  40 in total

1.  Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria.

Authors:  B Rosón; J Carratalà; J Dorca; A Casanova; F Manresa; F Gudiol
Journal:  Clin Infect Dis       Date:  2001-06-15       Impact factor: 9.079

2.  Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia.

Authors:  N C Dean; M P Silver; K A Bateman; B James; C J Hadlock; D Hale
Journal:  Am J Med       Date:  2001-04-15       Impact factor: 4.965

3.  Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission.

Authors:  Adamantia Liapikou; Miquel Ferrer; Eva Polverino; Valentina Balasso; Mariano Esperatti; Raquel Piñer; Jose Mensa; Nestor Luque; Santiago Ewig; Rosario Menendez; Michael S Niederman; Antoni Torres
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

4.  Deaths: final data for 2006.

Authors:  Melonie Heron; Donna L Hoyert; Sherry L Murphy; Jiaquan Xu; Kenneth D Kochanek; Betzaida Tejada-Vera
Journal:  Natl Vital Stat Rep       Date:  2009-04-17

5.  The impact of a delay in intensive care unit admission for community-acquired pneumonia.

Authors:  J Phua; W J Ngerng; T K Lim
Journal:  Eur Respir J       Date:  2010-02-25       Impact factor: 16.671

6.  Hospital admission decision for patients with community-acquired pneumonia: variability among physicians in an emergency department.

Authors:  Nathan C Dean; Jason P Jones; Dominik Aronsky; Samuel Brown; Caroline G Vines; Barbara E Jones; Todd Allen
Journal:  Ann Emerg Med       Date:  2011-09-09       Impact factor: 5.721

7.  Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia.

Authors:  Bertrand Renaud; Aline Santin; Eva Coma; Nicolas Camus; Dave Van Pelt; Jan Hayon; Merce Gurgui; Eric Roupie; Jérôme Hervé; Michael J Fine; Christian Brun-Buisson; José Labarère
Journal:  Crit Care Med       Date:  2009-11       Impact factor: 7.598

8.  Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia.

Authors:  Samuel M Brown; Barbara E Jones; Al R Jephson; Nathan C Dean
Journal:  Crit Care Med       Date:  2009-12       Impact factor: 7.598

9.  Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality.

Authors:  Marcos I Restrepo; Eric M Mortensen; Jordi Rello; Jennifer Brody; Antonio Anzueto
Journal:  Chest       Date:  2009-10-31       Impact factor: 9.410

10.  Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia.

Authors:  J Phua; K C See; Y H Chan; L S Widjaja; N W Aung; W J Ngerng; T K Lim
Journal:  Thorax       Date:  2009-04-21       Impact factor: 9.139

View more
  9 in total

1.  Implementation of Real-Time Electronic Clinical Decision Support for Emergency Department Patients with Pneumonia Across a Healthcare System.

Authors:  Nathan C Dean; Caroline G Vines; Jenna Rubin; Dave S Collingridge; Mark Mankivsky; Raj Srivastava; Barbara E Jones; Kathryn G Kuttler; Missy Walker; Nathan Jenson; Brandon J Webb; Todd L Allen; Peter J Haug
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

Review 2.  Year in review 2012: lung cancer, respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging.

Authors:  José M Porcel; Chi Chiu Leung; Marcos I Restrepo; Kazuhisa Takahashi; Pyng Lee
Journal:  Respirology       Date:  2013-04       Impact factor: 6.424

3.  Ameliorative effects of Qingfei Tongluo formula on experimental mycoplasmal pneumonia in mice.

Authors:  Yong-hong Jiang; Jian-er Yu; Ai-hua Guo; Xiao Li; Yan Lin; Zhi-yan Jiang; Zhen Xiao
Journal:  J Nat Med       Date:  2015-11-20       Impact factor: 2.343

Review 4.  Severe community-acquired pneumonia.

Authors:  Wendy I Sligl; Thomas J Marrie
Journal:  Crit Care Clin       Date:  2013-07       Impact factor: 3.598

5.  Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.

Authors:  Joshua P Metlay; Grant W Waterer; Ann C Long; Antonio Anzueto; Jan Brozek; Kristina Crothers; Laura A Cooley; Nathan C Dean; Michael J Fine; Scott A Flanders; Marie R Griffin; Mark L Metersky; Daniel M Musher; Marcos I Restrepo; Cynthia G Whitney
Journal:  Am J Respir Crit Care Med       Date:  2019-10-01       Impact factor: 21.405

6.  A Broad Learning System to Predict the 28-Day Mortality of Patients Hospitalized with Community-Acquired Pneumonia: A Case-Control Study.

Authors:  Jing Yuan; Xin Liu; Wen-Feng Wang; Jing-Jing Zhang
Journal:  Comput Math Methods Med       Date:  2022-03-04       Impact factor: 2.238

7.  Deploying an Electronic Clinical Decision Support Tool for Diagnosis and Treatment of Pneumonia Into Rural and Critical Access Hospitals: Utilization, Effect on Processes of Care, and Clinician Satisfaction.

Authors:  Jason R Carr; Barbara E Jones; Dave S Collingridge; Brandon J Webb; Caroline Vines; Blake Zobell; Todd L Allen; Rajendu Srivastava; Jenna Rubin; Nathan C Dean
Journal:  J Rural Health       Date:  2020-11-26       Impact factor: 4.333

Review 8.  Severe community-acquired pneumonia: timely management measures in the first 24 hours.

Authors:  Jason Phua; Nathan C Dean; Qi Guo; Win Sen Kuan; Hui Fang Lim; Tow Keang Lim
Journal:  Crit Care       Date:  2016-08-28       Impact factor: 9.097

9.  Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections.

Authors:  Ajay Sheshadri; Dimpy P Shah; Myrna Godoy; Jeremy J Erasmus; Juhee Song; Liang Li; Scott E Evans; Roy F Chemaly; Burton F Dickey; David E Ost
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.